News Updates from the 83rd Scientific Sessions
CGM technology has the potential for use as a preventative tool in diabetes and obesity, and researchers continue to learn more about the effects of CGM use in people living with diabetes who are treated with insulin and those who are not. Three experts, including Ronnie Aronson, MD, will discuss emerging evidence.
Read more
For many years, rural residents in the United States were healthier as a population than their urban counterparts. In the 1980s, that began to change. Four researchers, including Vasan Ramachandran, MD, DM, FACC, FAHA, will discuss this trend in the context of diabetes diagnosis and care. Read more
Taking an innovative idea for diabetes care from the bench to the bedside requires funding. Presenters including Kathryn Zavala, PhD, COO and BioTools Innovator Managing Director, MedTech Innovator, will discuss what investors look for in a pitch. Read more
Some of the diabetes management tools with the greatest efficacy are those that patients can use by themselves. Experts including Sarah S. Jaser, PhD, will discuss the impact tracking blood glucose levels, sleep quality, diet choices, and other behaviors can have in disease management while paying tribute to behavioral diabetes pioneer Mark Peyrot, PhD. Read more
Proper nutrition can help regulate diabetes. Christopher Gardner, PhD, will discuss the advantages of consuming a plant-based, whole-food diet, along with the health and global benefits of switching from animal protein to plant-based protein. Other presenters will discuss portion size and calorie density, and how processed foods impact energy balance. Read more
The ADA’s Precision Medicine in Diabetes Initiative aims to tap into the potential of individualized medicine to improve the lives of people with diabetes. Genetic testing is one component of this strategy to better understand the disease and refine diagnostics. Rinki Murphy, MBChB, FRACP, PhD, and other experts will discuss why endotypes matter in achieving better diabetes outcomes. Read more
Managing foot care is a challenge people living with diabetes face on a daily basis. David G. Armstrong, DPM, MD, PhD, and other panelists will present approaches providers can implement to help their patients living with diabetes get ahead of foot injuries and improve foot health. Read more
Presenter Matthias H. Tschöp, MD, shares insight into a symposium that begins Friday at 3:45 p.m. PT in Ballroom 20A-C at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Read More
In a symposium beginning Friday at 3:45 p.m. PT in Room 28 of the convention center, experts including Stephen E. Gitelman, MD, will present insights from studies of teplizumab and other agents, including abatacept and hydroxychloroquine, that have provided road maps to help delay the onset of type 1 diabetes. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Read More
In a symposium beginning Friday at 3:45 p.m. PT in Ballroom 20A-C of the convention center, investigators including W. Timothy Garvey, MD, will present results from the SURMOUNT 2 trial of tirzepatide. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Read More
During oral abstract presentations beginning Friday at 5:30 p.m. PT in Room 28 of the convention center, panelists including Ward Fickweiler, MD, will highlight a variety of factors and their potential associations with diabetic retinopathy. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Read More
Ann L. Albright, PhD, RDN, is the recipient of the 2023 Lois Jovanovic Transformative Woman in Diabetes Award. The award recognizes a woman who has made a significant impact in diabetes care, research, education, or public health. Dr. Albright will give remarks at the Women’s Interprofessional Network of the American Diabetes Association (WIN ADA) reception, which begins Friday at 6:45 p.m. PT in the ADA Booth (Booth 1047) at the Exhibit Hall (Halls D-F, Ground Level) in the convention center.
In a symposium beginning Friday at 3:45 p.m. PT in Ballroom 6A-B of the convention center, experts including Aimee Afable, PhD, MPH, will discuss the growing risk of diabetes in populations that immigrate to the U.S. and what may be leading to those risk factors. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Read More
Deborah Young-Hyman, PhD, FTOS, Fellow SBM, CDCES, is the recipient of the 2023 Richard R. Rubin Award. The award honors outstanding scientific achievement in the understanding of the behavioral aspects of diabetes. Dr. Young-Hyman will present the Richard R. Rubin Award Lecture on Friday at 2:00 p.m. PT in Room 30 at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Elizabeth Parks, PhD, is the recipient of the 2023 Edwin Bierman Award. The award honors outstanding scientific achievement in the prevention and treatment of macrovascular complications. Dr. Parks will present the Edwin Bierman Award Lecture on Friday at 2:00 p.m. PT in Room 28 at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
This debate features Ralph DeFronzo, MD, and David Nathan, MD, taking sides for and against initial combination therapy in type 2 diabetes mellitus. The session begins Friday at 12:45 p.m. PT in Room 30 at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Presenter Kevin M. Pantalone, DO, ECNU, FACE, shares insight into a symposium that begins Friday at 12:45 p.m. PT in Ballroom 20A-C at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Read More
Presenter Dana M. Lewis shares insight into a debate that begins Friday at 5:30 p.m. PT in Ballroom 20A-C at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Read More
This symposium includes presentations on how bacteria help the immune system tackle type 1 diabetes, cloaking beta-cells from immune-mediated damage, branched-chain amino acids and diabetes, neural changes that promote obesity and diabetes, and identifying and treating diabetes distress as part of routine type 1 diabetes care. The session begins Friday at 11:30 a.m. PT in Halls GH at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Scientific Sessions Meeting Planning Committee Chair Alice Y.Y. Cheng, MD, FRCPC, outlines some of the changes in this year's program and previews noteworthy sessions on Friday.
The 83rd Scientific Sessions kicks off with a welcome session and Keynote Address delivered by Francis Collins, MD, PhD, former director of the National Institutes of Health (NIH) and a pioneer in human genome research. The session, which includes a panel discussion following Dr. Collins' address, begins Friday at 10:30 a.m. PT in Halls GH at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
ADA Chief Scientific and Medical Officer Robert Gabbay, MD, PhD, and ADA Vice President of Research and Science Marlon Pragnell, PhD, highlight what attendees can expect at the 83rd Scientific Sessions.
Attendees in San Diego will experience new program features, educational offerings, and networking opportunities—all intended to enhance the overall Scientific Sessions experience, said Marlon Pragnell, PhD, ADA Vice President of Research & Science. More debates, audience polling, and extended time for questions are among the additions.
Read more
Scientific Sessions Meeting Planning Committee Chair Alice Y.Y. Cheng, MD, FRCPC, previews the program, featuring more than 190 sessions and 2,000 original research presentations on the latest clinical trial findings, highly anticipated study results, current hot topics, and emerging trends in diabetes research, prevention, and care. Read more
Carrying extra weight exacerbates diabetes and can lead to a variety of metabolic and biomechanical complications. In SURMOUNT 2, a GLP-1/GIP dual receptor agonist led to weight loss in patients with both obesity and type 2 diabetes to an extent previously unseen. Investigators including W. Timothy Garvey, MD, will present trial results at the Scientific Sessions. Read more
Since the publication of the Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes in 2021, the applicability of remission as a realistic treatment goal has evolved. A panel including Hertzel C. Gerstein, MD, MSc, FRCPC, will discuss the concept of remission in diabetes and its potential in research and patient care. Read more
Experts including Aimee Afable, PhD, MPH, will discuss the growing risk of diabetes in populations that immigrate to the U.S. and what may be leading to those risk factors. Discussions will include the challenges of adapting programs and approaches in treating and mitigating diabetes to meet the needs of culturally distinct communities. Read more
Last fall, the U.S. Food and Drug Administration approved teplizumab as the first disease-modifying therapy in type 1 diabetes. Experts including Stephen E. Gitelman, MD, will present insights from studies of teplizumab and other agents, including abatacept and hydroxychloroquine, that have provided road maps to help delay the onset of disease. Read more
People with diabetes are at risk for retinopathy. Ward Fickweiler, MD, will discuss research exploring the relationship between the presence of age-related macular degeneration and diabetic retinopathy severity in people with type 1 diabetes. Other panelists will discuss glucose management, prior cerebrovascular disease, and autonomous artificial intelligence diabetic eye exams. Read more